Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan

John Hang Leung, Chih Wen Chang, Agnes L.F. Chan, Hui Chu Lang*

*此作品的通信作者

研究成果: Article同行評審

指紋

深入研究「Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan」主題。共同形成了獨特的指紋。

Medicine & Life Sciences